|Articles|September 1, 2017
- BioPharm International-09-01-2017
- Volume 30
- Issue 9
BioPharm International, September 2017 Issue (PDF)
Click the title above to open the BioPharm International September 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
The Role of the Quality Unitover 8 years ago
Using Simulation to Address Capacity Limitationsover 8 years ago
The Human Cost of Congressional Stalematesover 8 years ago
Singular Developments Advance TFF Technologyover 8 years ago
Glass or Plastic? Container Material Choicesover 8 years ago
Real-Time Logisticsover 8 years ago
The Immune Context in Microbiological Testingover 8 years ago
Impact of Media Components on CQAs of Monoclonal Antibodiesover 8 years ago
Top Trends in Biopharmaceutical Manufacturing, 2017Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5
